- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BTK Degrader
Total 324 results
-
SanofiActive, not recruitingRelapsing Multiple SclerosisUnited States, Argentina, Belgium, Brazil, Canada, Chile, Croatia, Czechia, France, Germany, Greece, Hungary, India, Israel, Korea, Republic of, Latvia, Netherlands, Norway, Portugal, Puerto Rico, Russian Federation, Serbia, Slovakia, Spai... and more
-
French Innovative Leukemia OrganisationBristol-Myers SquibbCompletedSmall Lymphocytic Leukemia | CLL, Relapsed | CLL, Refractory | Bruton Tyrosine Kinase InhibitorFrance
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Central Nervous System Lymphoma | Central Nervous System B-Cell Non-Hodgkin Lymphoma | Recurrent Central Nervous System LymphomaUnited States
-
AstraZenecaActive, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Lymphoplasmacytic... and other conditionsUnited States, Canada
-
Boston Scientific CorporationActive, not recruitingCritical Limb IschemiaUnited States, France, Japan, Belgium, Netherlands
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type | Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell TypeUnited States, Saudi Arabia
-
M.D. Anderson Cancer CenterActive, not recruitingChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Novartis PharmaceuticalsCompletedChronic Spontaneous UrticariaJapan
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Mantle Cell Lymphoma | CCND1 Positive | CCND2 Positive | CCND3 Positive | CD20 Positive | Refractory Mantle Cell LymphomaUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaChina, Spain, Czechia, Taiwan, Italy, Japan, New Zealand, Poland, Hungary, United States, United Kingdom, Australia, Romania, Portugal, Korea, Republic of, Russian Federation, Austria, Brazil, Bulgaria, France, Ireland
-
National Institute of Neurological Disorders and...Active, not recruiting
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Acerta Pharma BVActive, not recruitingActivated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)United States, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Israel
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States, Canada, Singapore
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationWithdrawnLeukemia, Lymphocytic, Chronic, B-CellUnited States, Austria, Belgium, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Recurrent Cutaneous MelanomaUnited States
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Loxo Oncology, Inc.Eli Lilly and CompanyActive, not recruitingB-cell Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Korea, Republic of, Australia, Japan, United Kingdom, Italy, Poland, France, Switzerland, Sweden
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter Syndrome | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Loss of Chromosome 17pUnited States
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaAustria, Italy, Spain, United Kingdom, Belgium, Taiwan, France, Korea, Republic of, Hungary, United States, Ukraine, Canada, Australia, Germany, Israel, Czechia, Russian Federation, Slovakia, Poland, Bulgaria, New Zealand, Sweden, C... and more
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Malignant Solid NeoplasmUnited States
-
University of RochesterGlaxoSmithKlineCompletedChronic Lymphocytic Leukemia (CLL) | Waldenstrom Macroglobulinemia (WM)United States
-
Novartis PharmaceuticalsCompletedChronic Spontaneous UrticariaUnited States, India, Malaysia, Taiwan, Poland, United Kingdom, China, Thailand, Switzerland, Germany, Vietnam, Brazil, Russian Federation, Slovakia, Denmark, Canada, South Africa, Austria
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedDiffuse Large B-Cell Lymphoma UnclassifiableUnited States
-
Novartis PharmaceuticalsCompletedChronic Spontaneous UrticariaHungary, Taiwan, Italy, Korea, Republic of, Australia, France, Bulgaria, Czechia, Turkey, India, United States, Argentina, Mexico, Spain, Japan, Colombia, Russian Federation, Singapore, Puerto Rico
-
BioTeke USA, LLCCSSi Life SciencesCompleted
-
Northwestern UniversityNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCActive, not recruitingStage III Mantle Cell Lymphoma | Stage IV Mantle Cell Lymphoma | Contiguous Stage II Mantle Cell Lymphoma | Noncontiguous Stage II Mantle Cell Lymphoma | Stage I Mantle Cell LymphomaUnited States
-
ArQule, Inc., a subsidiary of Merck Sharp & Dohme...Active, not recruitingLymphoma, B-Cell | Follicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Richter's TransformationUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMantle Cell LymphomaUnited States
-
Abramson Cancer Center at Penn MedicineEnrolling by invitationHypertension | Atrial Fibrillation | Chronic Lymphocytic Leukemia | CardiotoxicityUnited States
-
Ohio State University Comprehensive Cancer CenterActive, not recruitingClassical Hodgkin LymphomaUnited States
-
Acerta Pharma BVNational Institutes of Health (NIH)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingRefractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL)United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Medtronic EndovascularActive, not recruitingPeripheral Arterial Disease | Critical Limb IschemiaSwitzerland, Belgium, France, Greece, Italy
-
Eli Lilly and CompanyLoxo Oncology, Inc.Completed
-
Acerta Pharma BVAstraZenecaActive, not recruitingMantle Cell Lymphoma (MCL)United States, Poland, Italy
-
Kami Maddocks, MDActive, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory/Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Kami Maddocks, MDPharmacyclics LLC.Active, not recruitingExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell LymphomaUnited States
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerChina
-
Abbott Medical DevicesActive, not recruiting
-
Spectranetics CorporationCompletedPeripheral Arterial DiseaseNetherlands, Germany, United Kingdom